Medindia LOGIN REGISTER
Medindia
Advertisement

Clinical Trial Shows How Shock Treatments Can Kill Children

by Bidita Debnath on March 15, 2013 at 12:23 AM
 Clinical Trial Shows How Shock Treatments Can Kill Children

In East Africa, the results from the Fluid Expansion as Supportive Therapy (FEAST) trial show that children who are given fluid to treat shock have an increased risk of death.

Death occured due to cardiovascular collapse at 48 hours. These findings in BioMed Central's open access journal BMC Medicine challenge the generally held idea that early and rapid reversal of shock by fluid resuscitation translates into longer-term survival benefits.

Advertisement

The FEAST trial was conducted in six African hospitals across Kenya, Tanzania and Uganda without intensive care facilities. It included 3000 children with shock caused by conditions including sepsis and malaria but excluded children with gastroenteritis, burns, who had undergone surgery or had severe malnutrition. All the children in the trial received standard treatments, depending on their illness including antibiotics, antimalarials, anticonvulsants, glucose or whole blood if anemic, but were randomly assigned to receiving fluid resuscitation or to a control group without fluid resuscitation.

Prof Kathryn Maitland, from the Wellcome Trust Centre for Clinical Tropical Medicine at Imperial College London, who led this study explained, "The children who were given this treatment (boluses) initially responded well compared to the control group. However, this did not translate into a better recovery at 48 hours - more children died in the group receiving boluses. The main cause of death, rather than fluid overload, was cardiovascular collapse."
Advertisement

This is surprising given that this treatment is standard practice elsewhere. The research team involved in this trial believe that in settings where there is a lack of intensive care facilities 'standard' procedures, such as fluid resuscitation, should not necessarily be used, especially when they have not been properly tested in clinical trials.

Commenting on this study Prof John Myburgh, from the University of New South Wales and The George Institute for Global Health, takes this one stage further and recommends that fluid resuscitation should be used with the same care as any potentially lethal drug, "Studies are beginning to show cracks in fluid resuscitation therapy and that careful monitoring is needed as well as a better understanding of dose and the way the therapy is given. The compelling results of this study from Africa question the wisdom of fluid bolus as therapy not only in pediatric patients but also in all critically ill patients."

This article marks the launch of an article collection on Medicine for Global Health in BMC Medicine. The collection will focus on public health initiatives, the development of health care policies, management of infectious and non-communicable diseases, cost-effectiveness studies and evidence-based guidelines which are needed to address the global burden of disease.

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Clinical Trials News

Plant Chloroplasts Offer Hope for  Huntington's Disease Treatment
A chloroplast plant enzyme - stromal processing peptidase, helps treat Huntington's disease by preventing protein clumping.
'Artificial Wombs' In Human Trials Await FDA Approval
FDA approval is sought for “artificial womb” clinical trials (mimicking lamb trials) in humans, that can potentially reduce mortality in premature babies.
Injecting Platelets Could be as Beneficial as Exercising to the Brain
Increasing the levels of platelet-derived factors in the body may lessen the effect of age-related degenerative changes and cognitive impairment in the brain.
Engineered Bacteria Offer New Hope for Early Cancer Detection
Constructing bacteria to become drug resistant only when they took up DNA containing cancer-associated changes, could be useful in detecting cancer.
Is Eli Lilly's Drug the Future of Obesity Treatment?
Eli Lilly's Mounjaro may prove an alternative to bariatric surgery, stated clinical trial results.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Clinical Trial Shows How Shock Treatments Can Kill Children Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests